Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
Mansoor Raza Mirza(Nordic Society of Gynecologic Oncology), Elisabeth Åvall Lundqvist(Nordic Society of Gynecologic Oncology), Michael J. Birrer(University of Alabama at Birmingham), René dePont Christensen(Nordic Society of Gynecologic Oncology), Gitte-Bettina Nyvang(Odense University Hospital), Susanne Malander(Nordic Society of Gynecologic Oncology), Maarit Anttila(Nordic Society of Gynecologic Oncology), Theresa L. Werner(University of Utah), Bente Lund(Nordic Society of Gynecologic Oncology), Gabriel Lindahl(Linköping University), Sakari Hietanen(Turku University Hospital), Ulla Peen(Nordic Society of Gynecologic Oncology), Maria Dimoula(Sahlgrenska University Hospital), Henrik Roed(Copenhagen University Hospital), Anja Ør Knudsen(Odense University Hospital), Synnöve Staff(Tampere University Hospital), Anders Krog Vistisen(Aalborg University Hospital), Line Bjørge(University of Bergen), Johanna Mäenpää(Tampere University Hospital)
Cited by 246
Abstract
Related Papers
No related papers found
Powered by citation graph analysis